Virtu Financial’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Virtu Financial’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-14,447	Closed	-$68K	–	1960
2020 Q3	$68K	Sell	14,447 -477	-3%	-$2.42K	0.01%	772
2020 Q2	$91K	Buy	+14,924	New	+$61.5K	0.01%	907
2019 Q3	–	Sell	-12,874	Closed	-$78K	–	1999
2019 Q2	$78K	Buy	+12,874	New	+$123K	﹤0.01%	1174
2019 Q1	–	Sell	-12,105	Closed	-$113K	–	2048
2018 Q4	$113K	Buy	+12,105	New	+$144K	0.01%	1105

Other funds holding FPRX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial's FPRX Position: Q4 2020 in Review

Virtu Financial sold out of Five Prime Therapeutics, Inc. (FPRX) in Q4 2020, closing a stake of 14,447 shares — an estimated $68K sold.

Virtu Financial first reported a position in FPRX in Q4 2018 and held it in 4 quarters. The position peaked at $113K in Q4 2018. 125 funds tracked by Wall St. Rank hold FPRX as of Q4 2020.

Virtu Financial reported no remaining Five Prime Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
Virtu Financial sold 14,447 Five Prime Therapeutics, Inc. shares in Q4 2020, an estimated $68K.
Virtu Financial first reported a position in Five Prime Therapeutics, Inc. in Q4 2018 and held it in 4 quarters.
Virtu Financial's Five Prime Therapeutics, Inc. position peaked at $113K in Q4 2018.
125 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2020.

Based on Virtu Financial's 13F filing for Q4 2020, filed 24 Feb 2021.